Anthony Federico
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Anthony Federico has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Stefano Monti
Section of Computational Biomedicine, Boston University Chobanian & Avedisian School of Medicine, Boston, MA 02118, USA
4 shared publications - Xaralabos Varelas
Department of Biochemistry, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts
3 shared publications - Joseph G. Kern
Department of Biochemistry, Boston University School of Medicine, Boston, Massachusetts, United States of America
2 shared publications - Alice Y. Cheung
Department of Biochemistry and Molecular Biology, Molecular Cell Biology and Plant Biology Programs, University of Massachusetts, Amherst, USA
1 shared publication Amy Mueller
Department of Medicine, Computational Biomedicine Section, Boston University School of Medicine, Boston, USA
1 shared publication- Andrew Tilston-Lunel
Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, USA
1 shared publication
Latest Publications
- Open Access
- 15 September 2023
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 29 (18_Supplem) , PO-020-020
Abstract PO-020: Gene regulatory network connectivity analysis identifies novel candidate effectors of HNSC tumorigenesis
The ever-increasing availability of publicly available cancer omics datasets makes it possible to perform in-silico studies aimed at elucidating disease mechanisms of action (MOAs) that may aid in therapeutic development. To this end, we recently developed Structure Learning for Hierarchical Networks (SHiNe) to model and distinguish direct and indirect signaling interactions from gene expression data to identify key signaling “hubs” and “bottlenecks”, associated crosstalk, and downstream targets that we used to identify potential effectors of head and neck squamous carcinoma (HNSC). SHiNe is an advanced gene regulatory network reconstruction approach optimized for learning multiple Markov networks in the “large p, small n” settings (i.e., large number of genes, small number of samples) typical of omics data. We applied SHiNe to the analysis of TCGA-HNSC RNA-seq data to learn HPV-negative and subtype- specific networks for previously validated molecular subtypes (Atypical, Basal, Classical, and Mesenchymal). SHiNe learned networks were sparser, with higher clustering coefficients, and more significantly enriched for protein-protein interactions than randomly simulated networks. Further annotation of the learned networks with multiple layers of omics information revealed several highly eigen-central genes in the HPV-negative network to be characterized by additional omics features. Examples included EP300, ranked 2nd by eigen-centrality with a single somatic mutation (SSM) rate of 7.87% (versus 4.59% in all other TCGA tumors), MYH9 (rank=12, SSM=6.1%), RPS6KA4 (rank=39, CNV Gain=16.5%), GNAI3 (rank=45, CNV Loss=10.55%), and CFL1 (rank=51, CNV Gain=20.72%). Community detection in the HPV(-) network structure using the Walktrap algorithm yielded 33 signaling communities, with the highest centrality community encompassing most of the central genes within the network (e.g., KLHL11, EP300, TAOK1, ADAM17, APAF1) and including genes strongly enriched for DNA repair and maintenance pathways. Co-localization analysis of omics features in the HPV-negative network identified within the most central community revealed a cluster of genes with copy number variation gain ≥ 25%, including ABCC5, ACTL6A, AP2M1, ATP11B, MAP3K13, NCBP2, PAK2, PIK3CA, PLD1, PRKCI, SKIL, TBL1XR1, and ZMAT3, with most of these genes located on the q arm of chromosome 3. While amplification of 3q26-29 is a known characteristic of HNSCC associated with poorer patient outcome, the MOA remains unclear, and thus our network analysis offers an opportunity to identify meaningful signaling interactions for therapeutic intervention of 3q26-29 mutated tumors. Indeed, we have identified candidate associations with the 3q26-29 amplicon genes that we are currently validating. We are also developing a graphical interface for the interactive inspection of the inferred networks. Taken together, these results highlight the potential for network-based analysis to support the study and identification of novel candidate regulators of head and neck tumorigenesis. Citation Format: Anthony Federico, Eric Reed, Maria Kukuruzinska, Xaralabos Varelas, Stefano Monti. Gene regulatory network connectivity analysis identifies novel candidate effectors of HNSC tumorigenesis [abstract]. In: Proceedings of the AACR-AHNS Head and Neck Cancer Conference: Innovating through Basic, Clinical, and Translational Research; 2023 Jul 7-8; Montreal, QC, Canada. Philadelphia (PA): AACR; Clin Cancer Res 2023;29(18_Suppl):Abstract nr PO-020.
- 15 September 2023
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 29 (18_Supplem) , PO-020-020
Open AccessAbstract PO-020: Gene regulatory network connectivity analysis identifies novel candidate effectors of HNSC tumorigenesis
The ever-increasing availability of publicly available cancer omics datasets makes it possible to perform in-silico studies aimed at elucidating disease mechanisms of action (MOAs) that may aid in therapeutic development. To this end, we recently developed Structure Learning for Hierarchical Networks (SHiNe) to model and distinguish direct and indirect signaling interactions from gene expression data to identify key signaling “hubs” and “bottlenecks”, associated crosstalk, and downstream targets that we used to identify potential effectors of head and neck squamous carcinoma (HNSC). SHiNe is an advanced gene regulatory network reconstruction approach optimized for learning multiple Markov networks in the “large p, small n” settings (i.e., large number of genes, small number of samples) typical of omics data. We applied SHiNe to the analysis of TCGA-HNSC RNA-seq data to learn HPV-negative and subtype- specific networks for previously validated molecular subtypes (Atypical, Basal, Classical, and Mesenchymal). SHiNe learned networks were sparser, with higher clustering coefficients, and more significantly enriched for protein-protein interactions than randomly simulated networks. Further annotation of the learned networks with multiple layers of omics information revealed several highly eigen-central genes in the HPV-negative network to be characterized by additional omics features. Examples included EP300, ranked 2nd by eigen-centrality with a single somatic mutation (SSM) rate of 7.87% (versus 4.59% in all other TCGA tumors), MYH9 (rank=12, SSM=6.1%), RPS6KA4 (rank=39, CNV Gain=16.5%), GNAI3 (rank=45, CNV Loss=10.55%), and CFL1 (rank=51, CNV Gain=20.72%). Community detection in the HPV(-) network structure using the Walktrap algorithm yielded 33 signaling communities, with the highest centrality community encompassing most of the central genes within the network (e.g., KLHL11, EP300, TAOK1, ADAM17, APAF1) and including genes strongly enriched for DNA repair and maintenance pathways. Co-localization analysis of omics features in the HPV-negative network identified within the most central community revealed a cluster of genes with copy number variation gain ≥ 25%, including ABCC5, ACTL6A, AP2M1, ATP11B, MAP3K13, NCBP2, PAK2, PIK3CA, PLD1, PRKCI, SKIL, TBL1XR1, and ZMAT3, with most of these genes located on the q arm of chromosome 3. While amplification of 3q26-29 is a known characteristic of HNSCC associated with poorer patient outcome, the MOA remains unclear, and thus our network analysis offers an opportunity to identify meaningful signaling interactions for therapeutic intervention of 3q26-29 mutated tumors. Indeed, we have identified candidate associations with the 3q26-29 amplicon genes that we are currently validating. We are also developing a graphical interface for the interactive inspection of the inferred networks. Taken together, these results highlight the potential for network-based analysis to support the study and identification of novel candidate regulators of head and neck tumorigenesis. Citation Format: Anthony Federico, Eric Reed, Maria Kukuruzinska, Xaralabos Varelas, Stefano Monti. Gene regulatory network connectivity analysis identifies novel candidate effectors of HNSC tumorigenesis [abstract]. In: Proceedings of the AACR-AHNS Head and Neck Cancer Conference: Innovating through Basic, Clinical, and Translational Research; 2023 Jul 7-8; Montreal, QC, Canada. Philadelphia (PA): AACR; Clin Cancer Res 2023;29(18_Suppl):Abstract nr PO-020.
- Open Access
- 18 May 2023
- Published by Public Library of Science (PLoS) in PLOS Computational Biology
- Vol. 19 (5) , e1011118
Structure learning for gene regulatory networks
Inference of biological network structures is often performed on high-dimensional data, yet is hindered by the limited sample size of high throughput “omics” data typically available. To overcome this challenge, often referred to as the “small n, large p problem,” we exploit known organizing principles of biological networks that are sparse, modular, and likely share a large portion of their underlying architecture. We present SHINE—Structure Learning for Hierarchical Networks—a framework for defining data-driven structural constraints and incorporating a shared learning paradigm for efficiently learning multiple Markov networks from high-dimensional data at large p/n ratios not previously feasible. We evaluated SHINE on Pan-Cancer data comprising 23 tumor types, and found that learned tumor-specific networks exhibit expected graph properties of real biological networks, recapture previously validated interactions, and recapitulate findings in literature. Application of SHINE to the analysis of subtype-specific breast cancer networks identified key genes and biological processes for tumor maintenance and survival as well as potential therapeutic targets for modulating known breast cancer disease genes.
- 18 May 2023
- Published by Public Library of Science (PLoS) in PLOS Computational Biology
- Vol. 19 (5) , e1011118
Open AccessStructure learning for gene regulatory networks
Inference of biological network structures is often performed on high-dimensional data, yet is hindered by the limited sample size of high throughput “omics” data typically available. To overcome this challenge, often referred to as the “small n, large p problem,” we exploit known organizing principles of biological networks that are sparse, modular, and likely share a large portion of their underlying architecture. We present SHINE—Structure Learning for Hierarchical Networks—a framework for defining data-driven structural constraints and incorporating a shared learning paradigm for efficiently learning multiple Markov networks from high-dimensional data at large p/n ratios not previously feasible. We evaluated SHINE on Pan-Cancer data comprising 23 tumor types, and found that learned tumor-specific networks exhibit expected graph properties of real biological networks, recapture previously validated interactions, and recapitulate findings in literature. Application of SHINE to the analysis of subtype-specific breast cancer networks identified key genes and biological processes for tumor maintenance and survival as well as potential therapeutic targets for modulating known breast cancer disease genes.
- Open Access
- 28 November 2022
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-13
Inactivation of LATS1/2 drives luminal-basal plasticity to initiate basal-like mammary carcinomas
Basal-like breast cancers, an aggressive breast cancer subtype that has poor treatment options, are thought to arise from luminal mammary epithelial cells that undergo basal plasticity through poorly understood mechanisms. Using genetic mouse models and ex vivo primary organoid cultures, we show that conditional co-deletion of the LATS1 and LATS2 kinases, key effectors of Hippo pathway signaling, in mature mammary luminal epithelial cells promotes the development of Krt14 and Sox9-expressing basal-like carcinomas that metastasize over time. Genetic co-deletion experiments revealed that phenotypes resulting from the loss of LATS1/2 activity are dependent on the transcriptional regulators YAP/TAZ. Gene expression analyses of LATS1/2-deleted mammary epithelial cells notably revealed a transcriptional program that associates with human basal-like breast cancers. Our study demonstrates in vivo roles for the LATS1/2 kinases in mammary epithelial homeostasis and luminal-basal fate control and implicates signaling networks induced upon the loss of LATS1/2 activity in the development of basal-like breast cancer.
- 28 November 2022
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-13
Open AccessInactivation of LATS1/2 drives luminal-basal plasticity to initiate basal-like mammary carcinomas
Basal-like breast cancers, an aggressive breast cancer subtype that has poor treatment options, are thought to arise from luminal mammary epithelial cells that undergo basal plasticity through poorly understood mechanisms. Using genetic mouse models and ex vivo primary organoid cultures, we show that conditional co-deletion of the LATS1 and LATS2 kinases, key effectors of Hippo pathway signaling, in mature mammary luminal epithelial cells promotes the development of Krt14 and Sox9-expressing basal-like carcinomas that metastasize over time. Genetic co-deletion experiments revealed that phenotypes resulting from the loss of LATS1/2 activity are dependent on the transcriptional regulators YAP/TAZ. Gene expression analyses of LATS1/2-deleted mammary epithelial cells notably revealed a transcriptional program that associates with human basal-like breast cancers. Our study demonstrates in vivo roles for the LATS1/2 kinases in mammary epithelial homeostasis and luminal-basal fate control and implicates signaling networks induced upon the loss of LATS1/2 activity in the development of basal-like breast cancer.
- Open Access
Contextualized Protein-Protein Interactions
- Top Cited Papers
- 18 March 2020
- Published by Springer Nature in Nature
- Vol. 579 (7800) , 561-566
FERONIA controls pectin- and nitric oxide-mediated male–female interaction
Species that propagate by sexual reproduction actively guard against the fertilization of an egg by multiple sperm (polyspermy). Flowering plants rely on pollen tubes to transport their immotile sperm to fertilize the female gametophytes inside ovules. In Arabidopsis, pollen tubes are guided by cysteine-rich chemoattractants to target the female gametophyte1,2. The FERONIA receptor kinase has a dual role in ensuring sperm delivery and blocking polyspermy3. It has previously been reported that FERONIA generates a female gametophyte environment that is required for sperm release4. Here we show that FERONIA controls several functionally linked conditions to prevent the penetration of female gametophytes by multiple pollen tubes in Arabidopsis. We demonstrate that FERONIA is crucial for maintaining de-esterified pectin at the filiform apparatus, a region of the cell wall at the entrance to the female gametophyte. Pollen tube arrival at the ovule triggers the accumulation of nitric oxide at the filiform apparatus in a process that is dependent on FERONIA and mediated by de-esterified pectin. Nitric oxide nitrosates both precursor and mature forms of the chemoattractant LURE11, respectively blocking its secretion and interaction with its receptor, to suppress pollen tube attraction. Our results elucidate a mechanism controlled by FERONIA in which the arrival of the first pollen tube alters ovular conditions to disengage pollen tube attraction and prevent the approach and penetration of the female gametophyte by late-arriving pollen tubes, thus averting polyspermy.
- 18 March 2020
- Published by Springer Nature in Nature
- Vol. 579 (7800) , 561-566
Top Cited PapersFERONIA controls pectin- and nitric oxide-mediated male–female interaction
Species that propagate by sexual reproduction actively guard against the fertilization of an egg by multiple sperm (polyspermy). Flowering plants rely on pollen tubes to transport their immotile sperm to fertilize the female gametophytes inside ovules. In Arabidopsis, pollen tubes are guided by cysteine-rich chemoattractants to target the female gametophyte1,2. The FERONIA receptor kinase has a dual role in ensuring sperm delivery and blocking polyspermy3. It has previously been reported that FERONIA generates a female gametophyte environment that is required for sperm release4. Here we show that FERONIA controls several functionally linked conditions to prevent the penetration of female gametophytes by multiple pollen tubes in Arabidopsis. We demonstrate that FERONIA is crucial for maintaining de-esterified pectin at the filiform apparatus, a region of the cell wall at the entrance to the female gametophyte. Pollen tube arrival at the ovule triggers the accumulation of nitric oxide at the filiform apparatus in a process that is dependent on FERONIA and mediated by de-esterified pectin. Nitric oxide nitrosates both precursor and mature forms of the chemoattractant LURE11, respectively blocking its secretion and interaction with its receptor, to suppress pollen tube attraction. Our results elucidate a mechanism controlled by FERONIA in which the arrival of the first pollen tube alters ovular conditions to disengage pollen tube attraction and prevent the approach and penetration of the female gametophyte by late-arriving pollen tubes, thus averting polyspermy.